ISABELLA DIMASO: Open Payments
NPI 1124456116 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 17 payments from 11 companies in 2025. Trend: 2023 $365 · 2024 $261 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $83 |
| Novo Nordisk Inc | 3 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Grifols USA, LLC | 1 | $35 |
| Insmed, Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Lilly USA, LLC | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
Products named: Cologuard Collection Kit, GEMTESA, Prolastin-C Liquid, Arikayce, TRINTELLIX, VRAYLAR, BREZTRI, Wegovy.
Industry payments across FL — which companies pay providers there.
